@spacanpanman Reaction seems a bit extreme already, but probably since it is so close to the last failure with BB-7. Are there any other names you would look at today outside of ASTS?
@Nibbler03806358 Noticed this as well and have not seen any mentions. guess we will have to wait for the minutes which they say are released a few weeks after the meeting.
@ErikOtto2 Just read your chemomab article. Any changes in opinion since that time? Seems like heading into the phase 3 trial it is something worth watching. Currently in on $ATYR and $SLS